Compugen (CGEN) Revenue & Revenue Breakdown
Compugen Revenue Highlights
Latest Revenue (Y)
$33.46M
Latest Revenue (Q)
$2.56M
Main Geography (Y)
Unites States
Compugen Revenue by Period
Compugen Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $33.46M | 346.12% |
| 2022-12-31 | $7.50M | 25.00% |
| 2021-12-31 | $6.00M | 200.00% |
| 2020-12-31 | $2.00M | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $17.80M | 100.00% |
| 2017-12-31 | - | -100.00% |
| 2016-12-31 | $712.00K | -92.33% |
| 2015-12-31 | $9.28M | -24.99% |
| 2014-12-31 | $12.37M | 248.46% |
| 2013-12-31 | $3.55M | 1366.53% |
| 2012-12-31 | $242.00K | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2010-12-31 | $1.11M | 346.00% |
| 2009-12-31 | $250.00K | -26.04% |
| 2008-12-31 | $338.00K | 87.78% |
| 2007-12-31 | $180.00K | -16.28% |
| 2006-12-31 | $215.00K | -66.72% |
| 2005-12-31 | $646.00K | -83.96% |
| 2004-12-31 | $4.03M | -54.37% |
| 2003-12-31 | $8.83M | -20.46% |
| 2002-12-31 | $11.10M | -2.32% |
| 2001-12-31 | $11.36M | 64.85% |
| 2000-12-31 | $6.89M | 112.88% |
| 1999-12-31 | $3.24M | - |
Compugen generated $33.46M in revenue during NA 2023, up 346.12% compared to the previous quarter, and up 187.97% compared to the same period a year ago.
Compugen Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $2.56M | -92.35% |
| 2023-12-31 | $33.46M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $7.50M | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $6.00M | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $2.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $7.80M | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $10.00M | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $53.00K | -24.29% |
| 2016-09-30 | $70.00K | -85.89% |
| 2016-06-30 | $496.00K | 433.33% |
| 2016-03-31 | $93.00K | -98.88% |
| 2015-12-31 | $8.31M | 3530.13% |
| 2015-09-30 | $229.00K | 2.69% |
| 2015-06-30 | $223.00K | -56.53% |
| 2015-03-31 | $513.00K | -92.17% |
| 2014-12-31 | $6.55M | 281.37% |
| 2014-09-30 | $1.72M | -12.53% |
| 2014-06-30 | $1.96M | -7.92% |
| 2014-03-31 | $2.13M | 20.17% |
| 2013-12-31 | $1.77M | 11.64% |
| 2013-09-30 | $1.59M | 7127.27% |
| 2013-06-30 | $22.00K | -86.42% |
| 2013-03-31 | $162.00K | 20.90% |
| 2012-12-31 | $134.00K | 24.07% |
| 2012-09-30 | $108.00K | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | -100.00% |
| 2010-12-31 | $190.00K | 100.00% |
| 2010-09-30 | - | -100.00% |
| 2010-06-30 | $800.00K | 540.00% |
| 2010-03-31 | $125.00K | 400.00% |
| 2009-12-31 | $25.00K | 100.00% |
| 2009-09-30 | - | -100.00% |
| 2009-06-30 | $225.00K | 100.00% |
| 2009-03-31 | - | -100.00% |
| 2008-12-31 | $11.00K | 83.33% |
| 2008-09-30 | $6.00K | -85.00% |
| 2008-06-30 | $40.00K | -85.77% |
| 2008-03-31 | $281.00K | 212.22% |
| 2007-12-31 | $90.00K | - |
Compugen generated $2.56M in revenue during Q1 2024, up -92.35% compared to the previous quarter, and up 34.12% compared to the same period a year ago.
Compugen Revenue Breakdown
Compugen Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|---|---|
| Europe | $10.00M | $7.50M | $6.00M | $2.00M | $17.80M |
| Unites States | $23.46M | - | - | - | - |
Latest
Compugen's latest annual revenue breakdown by geography, as of Dec 23: Unites States (70.11%), and Europe (29.89%).
Compugen Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BEAM | Beam Therapeutics | $377.71M | $14.27M |
| CRBU | Caribou Biosciences | $34.48M | $3.46M |
| CGEN | Compugen | $33.46M | $2.56M |
| SURF | Surface Oncology | $30.00M | - |
| VECT | VectivBio | $27.34M | $676.00K |
| ICCC | ImmuCell | $17.47M | $6.01B |
| ITOS | iTeos Therapeutics | $12.60M | $35.00M |
| CLGN | CollPlant Bio | $10.96M | $98.00K |
| EVGN | Evogene | $5.64M | $4.19M |
| BLRX | BioLineRx | $4.80M | $6.86M |
| PLUR | Pluri | $326.00K | $96.00K |
| ALLO | Allogene Therapeutics | $95.00K | - |
| EDIT | Editas Medicine | - | - |
| ANNX | Annexon | - | - |
| SANA | Sana Bio | - | - |